Pranav Constructions IPO Review: Cash vs Profit

Key takeaways

• The book is ₹351.03 crore: ₹315.60 crore fresh, ₹35.43 crore OFS (BioUrja) — about 90% of the issue enters the company. The book closes 9 Sep 2026.
• FY26 revenue from operations was ₹761.60 crore and PAT ₹71.32 crore. Operating cash flow was −₹92.60 crore in FY25 and −₹41.19 crore in FY26.
• 99.70% of FY26 revenue came from MCGM-region redevelopment. Promoters go 63.35% → 48.54%.
• At ₹124, post-issue mcap is ₹1,396.5 crore, or 19.6x FY26 — cheaper than Lodha / Godrej prints in broker tables, and those are not true peers.
• An unofficial GMP of ₹25 (~20%) was quoted on 6 Sep — unofficial, unregulated, often wrong.

The deal in one paragraph

Pranav Constructions rebuilds co-operative societies in Mumbai’s municipal limits. It does not buy large land banks. That is why the issue is 90% fresh and why brokers call the model asset-light. The abridged prospectus still shows the thing asset-light models can hide: two years of negative operating cash while PAT compounded. Nineteen times last year’s profit on a one-city book that has not converted earnings to cash is the offer. The checklist is at the end.

Data

Issue structure

Item	Figure	Units
Total issue	351.03	₹ cr
Fresh issue	315.60	₹ cr
OFS (BioUrja)	35.43	₹ cr
Price band	118–124	₹ / share
Lot	120	shares (₹14,880 at the cap)
Promoter holding	63.35 → 48.54	%
Window	7–9 Sep 2026	closes tomorrow
Listing (tentative)	15 Sep 2026	NSE + BSE

Source: Outlook Money; ET. SBI (via Hindu BL) says borrowings fell from ₹538 crore in FY26 reporting to ₹236 crore by Jul 2026; post-issue D/E is expected near 0.3x. LODHA and GODREJPROP in the frontmatter are listed comparables used by brokers, not recommendations and not true peers.

Financials (restated, ₹ cr)

	FY24	FY25	FY26
Revenue from operations	447.48	636.27	761.60
EBITDA	59.73	98.54	130.83
EBITDA margin	13.35%	15.49%	17.18%
PAT	39.62	62.25	71.32
Operating cash flow	+5.46	−92.60	−41.19
Net worth	88.37	175.59	246.70
Borrowings	99.34	196.50	258.44
EPS (₹)	4.66	7.22	8.18
RoCE	—	24.83%	24.34%

Units: ₹ crore except EPS and margins. Source: SEBI abridged prospectus; RoCE from ET. Pipeline (ET): 65 projects — 28 completed (1.42 msf), 20 under construction (1.63 msf), 17 upcoming (1.96 msf).

Valuation at the upper band

Metric	At ₹124
Post-issue mcap	₹1,396.5 cr
P/E FY26	19.6x
EV/EBITDA FY26	12.7x
Mcap / pre-sales	2.2x

Units: rupees crore and times. Source: Anand Rathi and SBI via Hindu Business Line. Broker peer lists mix national land-bank developers with this one-city redeveloper. Suraj Estate is closer in scale; its P/E in the same IPO Watch table was about 10x.

Subscription and unofficial GMP

Outlook Money (6 Sep) quoted an unofficial GMP of ₹25 versus ₹124 (~20%). Day-2 press cited overall subscription around 9.6x — an intraday print, not a close. Grey-market premiums are informal and often wrong.

Risks

• Negative operating cash in FY25 and FY26. Growth is WIP-funded.
• 99.7% one city, one product. An MCGM or society-agreement shock is company-level.
• Approval, RERA and execution delays on 20 live sites.
• Borrowings still material until the fresh issue lands.
• Broker “peers” are brand names, not clones.

What to watch

Five checks. At ₹124 this issue clears 1 of 5 (business / structure). Numbers fail on cash. Price is only cheap against the wrong peer set.

What would change my mind: two reported halves of positive operating cash — or a live print I can reconcile to a 10–12x cash-adjusted multiple on FY26. The book closes 9 Sep 2026. Listing is tentatively 15 Sep.

A companion video is planned; it will quote only this article and docs/ipo_analysis/pranav_constructions.md.

Sources

1. SEBI abridged prospectus — P&L, cash flow, shareholding — accessed 8 Sep 2026.
2. Outlook Money — issue, promoters, unofficial GMP — accessed 8 Sep 2026.
3. Economic Times — pipeline, RoCE — accessed 8 Sep 2026.
4. Hindu Business Line — 19.6x, EV/EBITDA, SBI deleveraging note — accessed 8 Sep 2026.

Disclaimer

AlphaResearch is not a SEBI-registered investment adviser or research analyst. This article is educational analysis based on publicly available information and is not investment advice or a recommendation to buy, sell, hold, subscribe to or avoid any security. Figures are taken from the sources listed above and may contain errors; verify them in the original filings. Investing in securities involves risk, including loss of principal. Consult a SEBI-registered adviser before making investment decisions.

Position disclosure: none. LODHA and GODREJPROP appear only as broker-cited comparables.